CN108218883A - A kind of simultaneously [2,3-b] quinoline and its synthesis technology and the application in anti-tumor aspect of pyrans - Google Patents
A kind of simultaneously [2,3-b] quinoline and its synthesis technology and the application in anti-tumor aspect of pyrans Download PDFInfo
- Publication number
- CN108218883A CN108218883A CN201611195869.1A CN201611195869A CN108218883A CN 108218883 A CN108218883 A CN 108218883A CN 201611195869 A CN201611195869 A CN 201611195869A CN 108218883 A CN108218883 A CN 108218883A
- Authority
- CN
- China
- Prior art keywords
- quinoline
- pyrans
- synthesis technology
- catalyst
- cell line
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/14—Ortho-condensed systems
- C07D491/153—Ortho-condensed systems the condensed system containing two rings with oxygen as ring hetero atom and one ring with nitrogen as ring hetero atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
The present invention relates to a kind of pyrans simultaneously [2,3 b] quinoline and its synthesis technology and the application in terms of anti-knurl, the synthesis technology utilizes multi-component reaction, using chemical formula II, malononitrile and 4 Hydroxycoumarins as raw material, solvent, catalyst and under microwave radiation pass through three component reactions, one-step synthesis obtains target compound, i.e. pyrans simultaneously [2,3 b] quinoline (Formulas I).The advantage of the invention is that：The synthesis technology of the present invention utilizes multi-component reaction, three kinds of raw materials a kind of pyrans simultaneously [2 has been synthesized by the method for " treating different things alike ", 3 b] quinoline, this is a kind of compound of quite stable, these compounds have human body hepatoma cell line HepG2 preferable external Inhibit proliferaton effect.
Description
Technical field
The invention belongs to technical field of organic synthesis, more particularly to pyrans simultaneously [2,3-b] quinoline and its synthesis work
Skill and the application in anti-tumor aspect.
Background technology
Pyrans is a kind of important heterocyclic compound, its derivative has extensive biology and pharmacological activity, such as anti-mistake
Quick effect (Witte, E.C.；Neubert,P.；Roesoh, A.DE 3427985,1986), hypoglycemic effect (Jiang Hong, Wang Li
Monarch, Zhao Zhixue, Beihua University's journal (natural science edition), 2001,2,489), active anticancer (Hyama, T.；Saimoto,H.JP
62181271,1987), available for treating anaphylaxis tracheitis (Chand, N.；Diamantis,W.；Sofia,
R.D.Br.J.Pharmacol., 1986,87,443), anti-depauperation (Brooks, G.T.；Ottridge,A.P.；Maee,
D.W.Pestic.SCi., 1988,22,41) and treatment diabetes (Suarez, M.；Ochoa,E.；Verdecia,Y.；
Martin,M.；Quinteiro,C.；Seoane,J.；Soto,J.L.；Novoa,N.；Blaton,N.；Peeters,
O.M.Tetrahedron, 1999,55,875) etc..Multi-functional pyrans is the essential building blocks of many natural products.
Quinoline is also benzo pyridine or azanaphthalene, is a kind of very important nitrogen-containing heterocycle compound (Madapa, S.；
Tusi,Z.；Batra, S.Curr.Org.Chem., 2008,12,1116), especially had a wide range of applications in pharmaceuticals industry.
Moreover, they are also many natural products and the parent nucleus of biologically active drug structure, such as：The peaceful alkali of chloroquine, camel, camptothecine.
By the continuous research of drug scholar, a large amount of quinoline derivatives are synthesized, and there is extensive biology to live for they
Property, such as：Anti-malarial, antibacterial, anti-inflammatory, antitumor, anti-diabetic, anti-asthma, anti-hypertension, anti-alzheimer your disease,
Platelet aggregation-against, AntiHIV1 RT activity isoreactivity (Kumar, S.；Bawa,S.；Gupta,H.Mini-Rev.Med.Chem.,2009,9,
1648)。
Pyranoquinoline is a kind of skeleton of alkaloid, it is present in rutaceae, such compound is due to having
Extensive pharmacology and bioactivity and attract attention ((a) Mabire, D.；Coupa,S.；Adelinet,A.；
Simonnet,Y.；Venet,M.；Wouters,R.；Lesage,A.S.J.；Beijsterveldt,L.V.；Bischoff,
F.J.Med.Chem.,2005,48,2134.(b)Michael,J.P.Nat.Prod.Rep.,2002,19,742.(c)
Michael,J.P.Nat.Prod.Rep.,2003,20,476.(d)Michael,J.P.Nat.Prod.Rep.,2004,21,
650.(e)Michael,J.P.Nat.Prod.Rep.,2005,22,627.).Pyranoquinoline class compound has antibacterial, resists
Platelet aggregation, anti-inflammatory, antiallergy, antihistamine isoreactivity ((a) Nahas, N.M.；Abdel-Hafez,
A.A.Heterocycl.Commun.,2005,11,263.(b)Chen,I.S.；Tsai,I.W.；Teng,C.M.；Chen,
J.J.；Chang,Y.L.；Ko,F.N.；Lu,M.C.；Pezzuto,J.M.Phytochemistry,1997,46,525.(c)
Amin,K.M.Egypt.J.Pharm.Sci.,1994,34,741.(d)Magesh,C.J.；Makesh,S.V.；
Perumal.P.T.Bioorg.Med.Chem.Lett.,2004,14,2035.(e)Yamada,N.；Kadowaki,S.；
Takahashi,K.；Umezu,K.Biochem.Pharmacol.,1992,44,1211.(f)Faber,K.；Stueckler,
H.；Kappe,T.J.Heterocycl.Chem.,1984,21,1177.(g)Johnson,J.V.；Rauckmann,B.S.；
Baccanari,D.P.；Roth.B.J.Med.Chem.,1989,32,1942.).Important biology is had based on pyranoquinoline
Activity, the synthesis technology of this kind of compound cause the interest of people, and Singh etc. reports 2- chloroquinolines -3- first under palladium chtalyst
Coupling Cyclization method (Chandra, the A. of aldehyde and alkynes；Singh,B.；Khanna,R.S.；Singh,
R.M.J.Org.Chem.,2009,74,5664.).Verma etc. reports the 2- alkynyl -3- quinoline aldehydes of catalysis of iodine and the ring of alcohol
Coupling reaction under change and palladium chtalyst has synthesized a series of pyrans simultaneously [4,3-b] quinoline (Aggarwal, T.；Imam,
M.；Kaushik,N.K.；Chauhan,V.S.；Verma,A.K.ACS Comb.Sci.,2011,13,530).Liu et al. in 2007
It reports cyclisation/open loop/cyclisation cascade reaction of penta formamide of 1- acetyl group-N- aryl rings under sulfuric acid catalysis and has synthesized a system
Row pyrans simultaneously [2,3-b] quinoline (Zhang, Q.；Zhang,Z.；Yan,Z.；Liu,Q.；Wang,Y.Org.Lett.,
2007,9,3651.).But these synthesis technology some needs use noble metal that as catalyst, some synthesis materials are not easy
It obtains.How the raw material being easy to get using some, the pyranoquinoline that some structure novels are synthesized by some simple methods spreads out
Biology has a very important significance.
Multi-component reaction refers to the starting material of three or three or more is primary or sequentially adds reaction, passes through one pot
The method boiled obtains target product, and each intermediate is the raw material of reaction in next step, and institute is included in the structure of final product
The one kind for having raw material segment efficiently synthesizes technique.Some raw materials simple and easy to get can be utilized by multi-component reaction, it is convenient, high
Compound of the effect ground structure with structure diversity and complexity, this method have been widely used for the conjunction of various heterocyclic compounds
Into ((a) Toure, B.B.；Hall,D.G.Chem.Rev.,2009,109,4439.(b)Domling,A.；Wang,W.；Wang,
K.Chem.Rev.,2012,112,3083.(c)Brauch,S.；van Berkel,S.S.；Westermann,
B.Chem.Soc.Rev.,2013,42,4948.)。
Invention content
The technical problem to be solved in the present invention is to provide a kind of pyrans simultaneously [2,3-b] quinoline and its synthesis technology,
The multi-component reaction participated in using some raw materials that are simple, being easy to get, is designed and is prepared into a kind of pyranoquinoline of structure novel
Derivative.
In order to solve the above technical problems, the technical scheme is that：A kind of pyrans simultaneously [2,3-b] quinoline,
Innovative point is：With structure shown in Formulas I：
Wherein, R1For-H, CH3O-, Cl- or (CH3)3Any one in C-.
A kind of synthesis technology of above-mentioned pyrans simultaneously [2,3-b] quinoline, innovative point are：With chemical formula II,
Malononitrile and 4 hydroxy coumarin are raw material, solvent, catalyst and under microwave radiation by three component reactions, a step
Synthesis obtains target compound, i.e. pyrans simultaneously [2,3-b] quinoline (Formulas I), and synthetic route is as follows：
Wherein, R1For-H, CH3O-, Cl- or (CH3)3Any one in C-.
Further, the molar ratio of the Formulae II, malononitrile, 4 hydroxy coumarin and catalyst is 1:1:1:0.1
~0.6, preferably 1:1:1:0.5.
Further, the solvent is ethyl alcohol, toluene, tetrahydrofuran, ethylene glycol, n,N-Dimethylformamide, water or second
One kind of nitrile, preferred alcohol.
Further, the catalyst can be alkali, and the alkali is sodium hydroxide, sodium carbonate, cesium carbonate or hexahydropyridine
In one kind；Catalyst can also be acid, and the acid is one kind in p-methyl benzenesulfonic acid or acetic acid；The catalyst can also be
Organic micromolecule catalyst L-PROLINE, preferably L-PROLINE.
Further, the reaction temperature is 80~110 DEG C, and the reaction time is 20~50min；Preferable reaction temperature is
100 DEG C, reaction time 30min.
Simultaneously in the application of anti-tumor aspect, innovative point is [2,3-b] quinoline a kind of above-mentioned pyrans：There is the IC of preferable external Inhibit proliferaton to human body hepatoma cell line HepG250Value reaches
6.72μM；There is preferable external Inhibit proliferaton to human body hepatoma cell line HepG2
IC50Value reaches 5.95 μM；Have to human body hepatoma cell line HepG2 preferable
External Inhibit proliferaton IC50Value reaches 1.02 μM；To human body hepatoma cell line
HepG2 has the IC of preferable external Inhibit proliferaton50Value reaches 6.86 μM.
The advantage of the invention is that：Three kinds of raw materials are passed through " one pot by the synthetic method of the present invention using multi-component reaction
Boil " method synthesized a kind of pyrans simultaneously [2,3-b] quinoline, this is a kind of compound of quite stable, these chemical combination
Object has human body hepatoma cell line HepG2 preferable external Inhibit proliferaton effect.
Specific embodiment
The following examples can make professional and technical personnel that the present invention be more fully understood, but therefore not send out this
It is bright to be limited among the embodiment described range.
A kind of pyrans simultaneously [2,3-b] quinoline has structure shown in Formulas I：
Wherein, R1For-H, CH3O-, Cl- or (CH3)3Any one in C-.
The synthesis technology of a kind of above-mentioned pyrans simultaneously [2,3-b] quinoline, with chemical formula II, malononitrile and 4- hydroxyls
Cumarin is raw material, and targeted is obtained by three component reactions, one-step synthesis in solvent, catalyst and under microwave radiation
Object, i.e. pyrans simultaneously [2,3-b] quinoline (Formulas I) are closed, synthetic route is as follows：
Wherein, R1For-H, CH3O-, Cl- or (CH3)3Any one in C-.
In the synthesis technology of the present invention, Formulae II, malononitrile, 4 hydroxy coumarin and catalyst molar ratio be 1:1:
1:0.1~0.6.
In the synthesis technology of the present invention, used solvent is ethyl alcohol, toluene, tetrahydrofuran, ethylene glycol, N, N- dimethyl
One kind of formamide, water or acetonitrile.
In the synthesis technology of the present invention, used catalyst can be alkali, can be acid or organic molecule
Catalyst；The alkali is one kind in sodium hydroxide, sodium carbonate, cesium carbonate or hexahydropyridine, and the acid is to toluene sulphur
One kind in acid or acetic acid, the organic micromolecule catalyst are L-PROLINE.
More specifically, the reaction temperature of the synthesis technology of the present invention is 80~110 DEG C, the reaction time is 20~50min.
By the screening of multiple reaction condition, and effect and the principle of Green Chemistry in view of reaction, preferably, really
Determine using ethyl alcohol as solvent, L-PROLINE is as catalyst, by Formula II compound, malononitrile, 4 hydroxy coumarin and catalyst
According to 1:1:1:0.5 molar ratio reacts 30min under conditions of 100 DEG C of reaction temperature, and the yield of obtained target product is most
It is high.
Below by following embodiment to this kind of pyrans simultaneously [2,3-b] quinoline synthesis technology carry out in detail citing and
Explanation：
Embodiment 1
2- chloroquinoline -3- formaldehyde (0.2mmol), malononitrile (0.2mmol) and 4 hydroxy coumarin (0.2mmol) are added in
Into 5mL microwave reaction pipes, L-PROLINE (0.1mmol) and ethyl alcohol 2mL are added, the seal of tube will be reacted, in advance stirring 10 seconds,
Mixture reacts 30 minutes under microwave radiation in 100 DEG C, after reaction, reaction system is cooled to room temperature, waits to be precipitated solid
It is filtered after body, then with the mixed solvent of DMF and water carries out being recrystallized to give 2- that (6- oxo -6,7- dihydros chromene is simultaneously
[3’,4’:5,6] pyrans simultaneously [2,3-b] quinoline -7- bases) malononitrile (Ia)：Yield 71%；
m.p.:274-276℃；IR(KBr,ν,cm-1):2917,2250,1701,1638,1607,1493,1404,1332,1244,
1204,1169,1151,1050,1025,987,769,754；1H NMR(400MHz,DMSO-d6)(δ,ppm):8.84(s,1H,
), ArH 8.15 (d, J=8.0Hz, 2H, ArH), 8.04 (d, J=8.4Hz, 1H, ArH), 7.94-7.90 (m, 1H, ArH),
7.86-7.82 (m, 1H, ArH), 7.70 (t, J=7.6Hz, 1H, ArH), 7.61 (d, J=8.4Hz, 1H, ArH), 7.57 (t, J
=8.0Hz, 1H, ArH), 5.38 (d, J=4.0Hz, 1H, CH), 5.34 (d, J=3.6Hz, 1H, CH)13C NMR(100MHz,
DMSO-d6)(δ,ppm):162.3,160.0,158.5,153.7,152.6,145.6,140.8,134.0,131.9,128.3,
127.6,127.0,126.9,125.2,123.0,117.0,113.2,113.1,112.7,112.4,98.4,35.7,35.2,
30.7,30.4.HRMS Calcd for C22H12N3O3[(M+H)+]366.0879；Found 366.0870.
Embodiment 2
According to the method for embodiment 1,2- chloroquinoline -3- formaldehyde is changed into 6- methoxyl group -2- chloroquinoline -3- formaldehyde, with L-
Proline is catalyst, is reacted 30 minutes under microwave radiation, after reaction, reaction system is cooled to room temperature, waits to be precipitated
It is filtered after solid, target product 2- (10- methoxyl group -6- oxos -6,7- is recrystallized to give with the mixed solvent of DMF and water
Dihydro chromene simultaneously [3 ', 4 ':5,6] pyrans simultaneously [2,3-b] quinoline -7- bases) malononitrile (Ib)：Yield 75%；m.p.:258-260℃；IR(KBr,ν,cm-1):2903,2254,
1686,1637,1609,1497,1455,1353,1236,1172,1113,1025,1005,993,794,747；1H NMR
(400MHz,DMSO-d6)(δ,ppm):8.69 (s, 1H, ArH), 8.14-8.11 (m, 1H, ArH), 7.94 (d, J=9.2Hz,
1H, ArH), 7.85-7.81 (m, 1H, ArH), 7.61-7.53 (m, 4H, ArH), 5.35 (d, J=3.6Hz, 1H, CH), 5.31
(d, J=3.6Hz, 1H, CH), 3.94 (s, 3H, CH3O).13C NMR(75MHz,DMSO-d6)(δ,ppm):160.5,159.0,
158.1,153.1,152.6,141.7,139.6,134.4,129.5,128.6,125.7,124.9,123.4,117.4,
113.7,113.6,113.2,112.9,106.4,98.7,56.2,35.7,30.8.HRMS Calcd for C23H14N3O4[(M+
H)+]396.0984；Found 396.0981.
Embodiment 3
According to the method for embodiment 1,2- chloroquinoline -3- formaldehyde is changed into 6- tertiary butyl -2- chloroquinoline -3- formaldehyde, with L-
Proline is catalyst, is reacted 30 minutes under microwave radiation, after reaction, reaction system is cooled to room temperature, waits to be precipitated
It is filtered after solid, target product 2- (10- tertiary butyl -6- oxos -6,7- is recrystallized to give with the mixed solvent of DMF and water
Dihydro chromene simultaneously [3 ', 4 ':5,6] pyrans simultaneously [2,3-b] quinoline -7- bases) malononitrile (Ic)：Yield 73%；m.p.:284-286℃；IR(KBr,ν,cm-1):2963,2255,
1702,1640,1610,1497,1460,1438,1396,1380,1366,1271,1183,1169,1150,1126,1098,
988,969,915,831；1H NMR(400MHz,DMSO-d6)(δ,ppm):8.82 (s, 1H, ArH), 8.17 (d, J=7.6Hz,
1H, ArH), 8.09-8.00 (m, 3H, ArH), 7.86 (t, J=8.0Hz, 1H, ArH), 7.64-7.58 (m, 2H, ArH), 5.38
(d, J=3.6Hz, 1H, CH), 5.34 (d, J=3.6Hz, 1H, CH), 1.45 (s, 9H, (CH3)3C).13C NMR(75MHz,
DMSO-d6)(δ,ppm):160.5,158.9,153.9,153.1,150.0,144.5,141.1,134.5,131.4,127.7,
127.1,125.7,123.4,117.4,113.7,113.2,112.9,98.8,35.8,35.3,31.3,31.9.HRMS Calcd
for C26H20N3O3[(M+H)+]422.1510；Found 422.1505.
Embodiment 4
According to the method for embodiment 1,2- chloroquinoline -3- formaldehyde is changed into 2,6- dichloroquinoline -3- formaldehyde, with L-PROLINE
For catalyst, reacted 30 minutes under microwave radiation, after reaction, reaction system is cooled to room temperature, after solid is precipitated
It is filtered, target product 2- (chloro- 6- oxos -6, the 7- dihydro chromenes of 10- is recrystallized to give with the mixed solvent of DMF and water
And [3 ', 4 ':5,6] pyrans simultaneously [2,3-b] quinoline -7- bases) malononitrile (Id)：Yield
69%；m.p.:284-286℃；IR(KBr,ν,cm-1):2903,2256,1689,1642,1604,1577,1417,1392,
1344,1272,1206,1119,1050,1024,991,930,823,767；1H NMR(400MHz,DMSO-d6)(δ,ppm):
8.82 (s, 1H, ArH), 8.32 (d, J=2.4Hz, 1H, ArH), 8.14-8.11 (m, 1H, ArH), 8.05 (d, J=9.2Hz,
1H, ArH), 7.92-7.90 (m, 1H, ArH), 7.86-7.82 (m, 1H, ArH), 7.61 (d, J=8.4Hz, 1H, ArH), 7.59-
7.55 (m, 1H, ArH), 5.38 (d, J=3.6Hz, 1H, CH), 5.34 (d, J=3.6Hz, 1H, CH)13C NMR(100MHz,
DMSO-d6)(δ,ppm):162.3,159.9,158.3,154.0,152.6,144.1,140.1,134.0,132.4,131.4,
129.7,127.6,126.9,125.2,122.9,116.9,114.4,113.1,112.6,112.4,98.4,35.2,
30.3.HRMS Calcd for C22H9ClN3O3[(M-H)-]398.0332；Found 398.0330.
Compound Ia~Id is in the application of anti-tumor aspect in 5 Examples 1 to 4 of embodiment
Use the antitumor activity of srb assay research compound Ia~Id.Compound dimethyl sulfoxide (DMSO) is dissolved, it is dilute
It releases.4000 HepG2 tumour cells are inoculated with per hole in 96 orifice plates, in 37 DEG C, 5%CO224 are cultivated in cell culture incubator
Hour.The compound (a concentration of 10 μM, 20 μM, 30 μM) of various concentration is added in per hole, jointly in 37 DEG C, 5%CO2Cell is trained
It supports and is incubated 48 hours in incubator, with DMSO (1%) for blank control, with srb assay (Sun, H.X.；He,H.W.；Zhang,
S.H.；Liu,T.G.；Ren,K.H.；He,Q.Y.；Shao, R.G.Cancer Gene Ther., 2009,16,693.) it determines simultaneously
Calculate IC50Value.The result shows that the series compound has significant resisting liver cancer activity, compound Ia, Ib, Ic, Id inhibit in vitro
HepG2 cell Proliferations all show certain bioactivity.Wherein, (6- oxo -6,7- dihydros chromene is simultaneously by compound 2-
[3’,4’:5,6] pyrans simultaneously [2,3-b] quinoline -7- bases) malononitrile (Ia), 2- (10- methoxyl group -6- oxo -6,7- dihydro colors
Alkene simultaneously [3 ', 4 ':5,6] pyrans simultaneously [2,3-b] quinoline -7- bases) malononitrile (Ib), 2- (10- tertiary butyl -6- oxo -6,7- dihydros
Change chromene simultaneously [3 ', 4 ':5,6] pyrans simultaneously [2,3-b] quinoline -7- bases) malononitrile (Ic) and 2- (the chloro- 6- oxos -6,7- two of 10-
Hydrogenate chromene simultaneously [3 ', 4 ':5,6] pyrans simultaneously [2,3-b] quinoline -7- bases) malononitrile (Id) has good antitumor activity, it
IC50Value is as follows：
Basic principle of the invention and main feature and advantages of the present invention has been shown and described above.
It should be understood by those skilled in the art that the present invention is not limited to the above embodiments, above-described embodiment and explanation
Merely illustrating the principles of the invention described in book, without departing from the spirit and scope of the present invention, the present invention also have
Various changes and modifications, these changes and improvements all fall within the protetion scope of the claimed invention.The claimed scope of the invention
It is defined by the appending claims and its equivalent thereof.
Claims (7)
1. a kind of pyrans simultaneously [2,3-b] quinoline, it is characterised in that：With structure shown in Formulas I：
Wherein, R1For-H, CH3O-, Cl- or (CH3)3Any one in C-.
2. a kind of synthesis technology of pyrans as described in claim 1 simultaneously [2,3-b] quinoline, it is characterised in that：To change
Formula II, malononitrile and 4 hydroxy coumarin be raw material, solvent, catalyst and under microwave radiation by three components it is anti-
Should, one-step synthesis obtains target compound, i.e. pyrans simultaneously [2,3-b] quinoline (Formulas I), and synthetic route is as follows：
Wherein, R1For-H, CH3O-, Cl- or (CH3)3Any one in C-.
3. the synthesis technology of pyrans according to claim 2 simultaneously [2,3-b] quinoline, it is characterised in that：Describedization
The molar ratio for learning Formula II, malononitrile, 4 hydroxy coumarin and catalyst is 1:1:1:0.1~0.6, preferably 1:1:1:0.5.
4. the synthesis technology of pyrans according to claim 2 simultaneously [2,3-b] quinoline, it is characterised in that：It is described molten
Agent is ethyl alcohol, toluene, tetrahydrofuran, ethylene glycol, n,N-Dimethylformamide, one kind of water or acetonitrile, preferred alcohol.
5. the synthesis technology of pyrans according to claim 2 simultaneously [2,3-b] quinoline, it is characterised in that：It is described to urge
Agent can be alkali, and the alkali is one kind in sodium hydroxide, sodium carbonate, cesium carbonate or hexahydropyridine；Catalyst can also be
Acid, the acid are one kind in p-methyl benzenesulfonic acid or acetic acid；The catalyst can also be organic micromolecule catalyst L- dried meat ammonia
Acid, preferably L-PROLINE.
6. the synthesis technology of pyrans according to claim 2 simultaneously [2,3-b] quinoline, it is characterised in that：It is described anti-
It is 80~110 DEG C to answer temperature, and the reaction time is 20~50min；Preferable reaction temperature is 100 DEG C, reaction time 30min.
Simultaneously in the application of anti-tumor aspect, 7. feature exists [2,3-b] quinoline a kind of pyrans described in claim 1
In：There is the IC of preferable external Inhibit proliferaton to human body hepatoma cell line HepG250Value reaches
To 6.72 μM；There is preferable external inhibition to increase to human body hepatoma cell line HepG2
The IC grown50Value reaches 5.95 μM；To human body hepatoma cell line HepG2 have compared with
The IC of good external Inhibit proliferaton50Value reaches 1.02 μM；To human body hepatoma cell line
HepG2 has the IC of preferable external Inhibit proliferaton50Value reaches 6.86 μM.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201611195869.1A CN108218883B (en) | 2016-12-22 | 2016-12-22 | Pyrano [2,3-b ] quinoline derivative, synthesis process thereof and application thereof in anti-tumor aspect |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201611195869.1A CN108218883B (en) | 2016-12-22 | 2016-12-22 | Pyrano [2,3-b ] quinoline derivative, synthesis process thereof and application thereof in anti-tumor aspect |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN108218883A true CN108218883A (en) | 2018-06-29 |
| CN108218883B CN108218883B (en) | 2021-11-23 |
Family
ID=62656046
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201611195869.1A Active CN108218883B (en) | 2016-12-22 | 2016-12-22 | Pyrano [2,3-b ] quinoline derivative, synthesis process thereof and application thereof in anti-tumor aspect |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN108218883B (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107098914A (en) * | 2017-05-18 | 2017-08-29 | 江苏理工学院 | A kind of chromene simultaneously [3 ', 4 ':5,6] pyrans simultaneously [2,3 b] quinoline and its preparation method and application |
| CN110590772A (en) * | 2019-09-16 | 2019-12-20 | 江苏理工学院 | Pyrazolo [3,4-b ] pyridine modified coumarin derivative and preparation method thereof |
| CN113234083A (en) * | 2021-04-16 | 2021-08-10 | 华南理工大学 | Tetrahydroquinoline pyran compound and preparation method and application thereof |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102584841A (en) * | 2011-12-16 | 2012-07-18 | 浙江工业大学 | Quinoline coumarin derivate and preparation method and application thereof |
| CN102757446A (en) * | 2012-07-30 | 2012-10-31 | 李佰林 | Synthesis method of pyranocoumarin derivatives |
| CN105037381A (en) * | 2015-06-25 | 2015-11-11 | 安徽工业大学 | Green catalytic preparation method of pyrano[4,3-b]pyran derivative |
| CN105111179A (en) * | 2015-08-11 | 2015-12-02 | 安徽工业大学 | Method for catalytically preparing substituted benzo[g]chromene derivative |
| CN105801587A (en) * | 2016-05-17 | 2016-07-27 | 安徽工业大学 | Environment-friendly method for preparing pyrano[2,3-d]pyrimidone derivate through catalysis |
| CN105801595A (en) * | 2016-05-17 | 2016-07-27 | 安徽工业大学 | Method for catalytically preparing 4,5-dihydropyran[c]chromene derivative |
-
2016
- 2016-12-22 CN CN201611195869.1A patent/CN108218883B/en active Active
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102584841A (en) * | 2011-12-16 | 2012-07-18 | 浙江工业大学 | Quinoline coumarin derivate and preparation method and application thereof |
| CN102757446A (en) * | 2012-07-30 | 2012-10-31 | 李佰林 | Synthesis method of pyranocoumarin derivatives |
| CN105037381A (en) * | 2015-06-25 | 2015-11-11 | 安徽工业大学 | Green catalytic preparation method of pyrano[4,3-b]pyran derivative |
| CN105111179A (en) * | 2015-08-11 | 2015-12-02 | 安徽工业大学 | Method for catalytically preparing substituted benzo[g]chromene derivative |
| CN105801587A (en) * | 2016-05-17 | 2016-07-27 | 安徽工业大学 | Environment-friendly method for preparing pyrano[2,3-d]pyrimidone derivate through catalysis |
| CN105801595A (en) * | 2016-05-17 | 2016-07-27 | 安徽工业大学 | Method for catalytically preparing 4,5-dihydropyran[c]chromene derivative |
Non-Patent Citations (1)
| Title |
|---|
| 姚孟建: "绿色高效合成吡喃并喹啉衍生物的研究", 《中国优秀硕士学位论文全文数据库 工程科技I辑》 * |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107098914A (en) * | 2017-05-18 | 2017-08-29 | 江苏理工学院 | A kind of chromene simultaneously [3 ', 4 ':5,6] pyrans simultaneously [2,3 b] quinoline and its preparation method and application |
| CN110590772A (en) * | 2019-09-16 | 2019-12-20 | 江苏理工学院 | Pyrazolo [3,4-b ] pyridine modified coumarin derivative and preparation method thereof |
| CN113234083A (en) * | 2021-04-16 | 2021-08-10 | 华南理工大学 | Tetrahydroquinoline pyran compound and preparation method and application thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN108218883B (en) | 2021-11-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Saikh et al. | Synthesis of 3-methyl-4-arylmethylene isoxazole-5 (4H)-ones by visible light in aqueous ethanol | |
| Boominathan et al. | Efficient atom economical one-pot multicomponent synthesis of densely functionalized 4H-chromene derivatives | |
| Altug et al. | An efficient one-pot multicomponent approach to 5-amino-7-aryl-8-nitrothiazolo [3, 2-a] pyridines | |
| Yadav et al. | Visible light induced, catalyst free, convenient synthesis of chromene nucleus and its derivatives using water–ethanol mixture as a solvent | |
| Matiychuk et al. | A new domino-Knoevenagel–hetero-Diels–Alder reaction | |
| Yen et al. | Design and synthesis of gambogic acid analogs as potent cytotoxic and anti-inflammatory agents | |
| CN108218883A (en) | A kind of simultaneously [2,3-b] quinoline and its synthesis technology and the application in anti-tumor aspect of pyrans | |
| Li et al. | One-step synthesis of furocoumarins via oxidative annulation of 4-hydroxycoumarins with DDQ | |
| Rao et al. | Catalyst-free one-pot domino reactions for selective synthesis of functionalized 2, 8-oxazabicyclo [3.3. 1]-nonanes and 5 H-indeno [1, 2-b] pyridin-5-ones | |
| CN106167490A (en) | One class is containing the imidazo naphthalimide analog derivative of indole and synthesis thereof and application | |
| Yadav et al. | Three-component coupling reactions of isoquinolines, dimethyl acetylenedicarboxylate and indoles: a facile synthesis of 3-indolyl-1, 2-dihydro-2-isoquinolinyl-2-butenedioate | |
| Zhang et al. | Three-component domino cyclization of novel carbazole and indole fused pyrano [2, 3-c] pyridine derivatives | |
| Alizadeh et al. | An efficient synthesis of novel functionalized benzo [h] pyrano [2, 3-b] quinolines and pyrano [2, 3-b] quinoline derivatives via one-pot multicomponent reactions | |
| CN107573327A (en) | Indazolecarboxamides Pyridione derivatives and its production and use | |
| Maurya et al. | A carbanion induced synthesis of highly congested pyrazole and imidazole containing heterocycles | |
| CN106946868A (en) | Nitric oxide donator type coumarin derivative, its preparation method and medical usage | |
| CN106810560A (en) | A kind of synthetic method of 8 azepine cumarin and its application in antineoplastic | |
| Ghahremanzadeh et al. | A rapid and high efficient microwave promoted multicomponent domino reaction for the synthesis of spirooxindole derivatives | |
| CN108727329A (en) | N- hydroxyethyl formamide base substituted diphenylamines and xanthene and its application | |
| CN109666006B (en) | Aryl derivative bithiazole compound and preparation method and application thereof | |
| Korotaev et al. | Synthesis of 5-(trifluoromethyl)-5H-chromeno [3, 4-b] pyridines from 3-nitro-2-(trifluoromethyl)-2H-chromenes and aminoenones derived from acetylacetone and cyclic amines | |
| Wang et al. | Copper‐Assisted/Copper‐Free Synthesis of Functionalized Dibenzo [b, f] oxepins and Their Analogs via a One‐Pot Tandem Reaction | |
| CN108218882A (en) | A kind of simultaneously [2,3-b] quinoline and preparation method thereof and the application in anti-tumor aspect of pyrans | |
| CN102285934A (en) | Spirocycle dienone derivates as well as preparation method and application thereof | |
| CN106632364A (en) | Pyrano[2,3-b]quinoline derivative as well as synthesis method and anti-tumor application thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |